AI assistant
Sending…
Anika Therapeutics, Inc. — Director's Dealing 2011
Aug 10, 2011
33997_dirs_2011-08-10_bfd0fb92-4b58-4eae-9055-037184fe5019.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANIKA THERAPEUTICS INC (ANIK)
CIK: 0000898437
Period of Report: 2011-08-09
Reporting Person: Thompson Jeffery S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-08-09 | Common Stock | A | 1980 | $5.99 | Acquired | 12473 | Direct |
Footnotes
F1: Shares of Anika Therapeutics, Inc. common stock purchased on the open market
More from Anika Therapeutics, Inc.
Proxy Solicitation & Information Statement
2026
Jun 1
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 18